Sunday 18 October 2026
Export ADGM’s income statement to Excel — free account
Adagio Medical Holdings, Inc.
ADGM Healthcare Medical Devices
Adagio Medical Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $602,000.00, up 100.7% from fiscal 2023. In the quarter to June 2026, revenue fell 33.5%, EPS fell 15.4%, free cash flow fell 12.9% and total debt rose 46.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.10
0.00
0.00%
Follow ADGM
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | — |
P/S ratio |
— | — | — | — | — | 0.00 | 27.19 | — |
Altman Z-Score |
— | — | — | — | — | (48.16) | (6.98) | — |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | (132.61) | (13.31) | — |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | — |
P/Operating CF |
— | — | — | — | — | (1.17) | (2.30) | — |
P/B ratio |
— | — | — | — | — | 0.00 | 0.82 | — |
Price to Tangible BV |
— | — | — | — | — | 0.00 | 0.00 | — |
EV/Sales |
— | — | — | — | — | 0.00 | 19.70 | — |
EV/EBITDA |
— | — | — | — | — | 0.00 | 0.00 | — |
EV/Operating CF |
— | — | — | — | — | (0.28) | (0.40) | — |
EV/FCF |
— | — | — | — | — | (0.27) | (0.38) | — |
Quick Ratio |
— | 0.00 | 0.00 | 0.08 | 0.01 | 0.03 | 2.66 | 2.08 |
Current Ratio |
— | 0.03 | 0.03 | 0.15 | 0.02 | 0.11 | 3.27 | 2.44 |
Net Debt/EBITDA |
— | 0.00 | 0.00 | 0.08 | 0.09 | 0.05 | 0.09 | (0.19) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.10% | 33.18% | 48.64% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.81 | 1.70 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
Operating CF/Net income |
— | 0.00 | 0.00 | 0.16 | (0.45) | 0.70 | 0.39 | 0.76 |
Capex/Depreciation |
— | — | — | — | — | (0.62) | (0.05) | (0.39) |
Interest Coverage |
— | — | — | — | — | (16.84) | (28.79) | (7.53) |
| — | 100.00% | 100.00% | 127.31% | (11.27%) | 52.02% | 133.87% | (155.25%) | |
| — | (63.53%) | (31.76%) | (8.72%) | 0.71% | (46.14%) | (271.53%) | (54.71%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (341.51%) | (83.74%) |
Return on Tangible Assets |
— | 24.91% | 24.91% | 128.28% | (17.43%) | 90.34% | (383.90%) | (187.42%) |
Average Days of Receivables |
— | — | — | — | — | 86.38 | 21.22 | — |
Research and Development Expense of Revenue |
— | — | — | — | — | 5,133.00% | 2,029.73% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 3,845.67% | 3,326.08% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 | 0.48 |
Share Based Compensation of Revenue |
— | — | — | — | — | 147.33% | 106.64% | 0.00% |
Graham Net Nets |
— | — | — | — | — | (5.08) | (0.19) | — |
Graham Number |
— | — | — | — | — | 433.79 | 0.00 | — |
Earnings Yield |
— | — | — | — | — | (440.48%) | (458.46%) | — |
Free Cash Flow Yield |
— | — | — | — | — | (312.90%) | (190.04%) | — |
Revenue per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.39 | 0.04 | 0.00 |
Operating CF per Share |
— | 0.00 | 0.00 | (0.29) | (0.13) | (33.75) | (1.89) | (1.15) |
Capex per Share |
— | — | 0.00 | 0.00 | 0.00 | (0.45) | (0.11) | (0.02) |
Free Cash Flow per Share |
— | 0.00 | 0.00 | (0.29) | (0.13) | (34.20) | (2.00) | (1.17) |
Cash per Share |
— | — | 0.00 | 0.14 | 0.02 | 1.82 | 1.32 | 1.03 |
Shareholders Equity per Share |
— | 0.00 | 0.00 | (2.84) | (2.31) | (53.36) | 1.28 | 0.75 |
Interest Debt per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 0.00 | (2.84) | (2.31) | (53.36) | 1.28 | 0.75 |
Free Cash Flow |
— | 0.00 | 0.00 | (1.07) | (0.49) | (25.99) | (31.11) | (19.39) |
Working Capital |
— | (0.05) | (0.05) | (5.12) | (6.12) | (41.99) | 17.59 | 11.85 |
Capital Expenditures |
— | — | — | — | — | (0.34) | (1.65) | (0.37) |
Net Current Asset Value |
— | (0.05) | (0.05) | (159.85) | (160.27) | (42.19) | (3.19) | (10.77) |
EV/EBIT |
— | — | — | — | — | 0.00 | 0.00 | — |
Capex to Sales |
— | — | — | — | — | 1.13 | 2.74 | 0.00 |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | — | — | — | — | 0.37 | 16.18 | 0.63 |
Cash ROIC |
— | 0.00% | 0.00% | 10.93% | 5.68% | 66.60% | (54.98%) | (38.36%) |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 11.36 | — |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.67 | 0.99 | 0.35 |
Inventory Turnover |
— | — | — | — | — | 0.00 | 1.13 | 0.32 |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 1,070.41 | 312.42 | 577.38 |
Days of Inventory on Hand |
— | — | — | — | — | 928.43 | 282.28 | 892.22 |
Average Receivables |
— | — | — | — | — | — | 0.05 | — |
Average Payables |
— | 0.03 | 0.03 | 0.10 | 0.12 | 1.95 | 3.34 | 1.96 |
Average Inventory |
— | — | — | — | — | — | 2.94 | 2.12 |
Average Assets |
— | 0.02 | 0.04 | 75.23 | 151.10 | 79.30 | 27.64 | 45.85 |
Average Common Equity |
— | (0.01) | (0.01) | (5.15) | (9.47) | (70.33) | (56.06) | 16.16 |
Columns are period end dates